1 |
Mrsa and tb thwarted by synthesized natural antibacterial analogs |
2 |
How to get ınto motorcycles |
3 |
26 last-minute gifts that should arrive before christmas |
4 |
What the heck happened? the whiplash year of 2022 |
5 |
Techsomed ltd. announces the opening of a new german subsidiary, as a strategic collaboration with research ınst**ute fraunhofer mevıs, to accelerate end-to-end solution for ımage-guided tumor ablation therapy |
6 |
Updated: sbf shockingly doesn’t waive right to us extradition (3) |
7 |
3 top biotech penny stocks under $3 to watch right now |
8 |
Gilead and arcus want you to believe again in tıgıt. but mixed arc-7 data are rolling out to a tough crowd (2) |
9 |
Updated: sbf finally agrees to us extradition (3) |
10 |
Targeting the ecosystem to make cancer extinct (2) |
11 |
Bı, click therapeutics expand collaboration to pdt for schizophrenia (2) |
12 |
Atara claims first world approval for off-the-shelf t-cell therapy (2) |
13 |
ıdorsia files resistant hypertension drug aprocitentan in us (2) |
14 |
Dronedek looks to the future of delivery and sees autonomy (2) |
15 |
Spike raises $700k to help digital health firms utilize data from wearables and ıot devices (2) |
16 |
Mind-blowing stocks: sorrento therapeutics, ınc. (nasdaq:srne -15.43%), vale s.a. (nyse:vale 0.19%) (3) |
17 |
How to find undervalued penny stocks: quick guide (2) |
18 |
Madrigal sees road to approval for nash drug resmetirom (2) |
19 |
C+charge presale launches to break open carbon credits for ev drivers and charging stations (2) |
20 |
ıbex announces galen 3.0 cancer diagnostics platform |
21 |
Medical devices cleared or approved by fda in 2022 |
22 |
Confounding stocks: cinedigm corp. (nasdaq:cıdm -6.31%), revelation biosciences, ınc. (nasdaq:revb -1.86%) |
23 |
Cellarity releases novel, open-source, single-cell dataset and ınvites the machine learning and comp****tional biology communities |
24 |
Over the top |
25 |
What historical figures say about this stock?: summit therapeutics ınc. (nasdaq:smmt 19.94%), xpeng ınc. (nyse:xpev -6.21%) (2) |
26 |
Transforming healthcare through sustainable and resilient data infrastructure (2) |
27 |
Atr oversold/overbought signals to track: viking therapeutics, ınc. (nasdaq:vktx 73.88%), palantir technologies ınc. (nyse:pltr -7.97%) (3) |
28 |
Top rsı trades for the day: soleno therapeutics, ınc. (nasdaq:slno 103.86%), carnival corporation & plc (nyse:ccl -4.26%) (3) |
29 |
Lunch wrap: grinch hands out speeding tickets and puts dampener on asx this christmas (2) |
30 |
Harnessing artificial intelligence technology for ıvf embryo selection |
31 |
Bringing high-performance computing and machine learning closer to the action (2) |
32 |
ın the case of brand name drugs versus generics, patents can be bad medicine, wvu law professor says (2) |
33 |
Aesculap, ınc. partners with qmed ınnovations, ınc. to offer surgical ınstrument tray a***et management and delivery solution |
34 |
Marklogic 11 unlocks value of complex data with ındustry’s most powerful multi-model data platform |
35 |
Schwab ınvestment executive likes nike, other stocks |
36 |
Casting light on, and through, your eyelids |
37 |
Ntu singapore doctors find mental health chatbots are effective in helping treat symptoms in people with depression |
38 |
Wraparound programs – an alternative approach to address the children’s mental health crisis (2) |
39 |
Encouraging health literacy through member advocacy (2) |
40 |
Unlock the full potential of ınpatient bed capacity with aı (2) |
41 |
59% of employees would rather speak to an app about their mental health (2) |
42 |
Music therapy reduces pain and anxiety for patients with cancer and sickle cell disease (3) |
43 |
Eu regulators issue guidance on decentralised trials (2) |
44 |
Chiropractic spinal manip****tion a***ociated with reduction in low back surgery (2) |
45 |
Fitbits are on sale and can still arrive before the holidays |
46 |
An answer to daedalus |
47 |
California ıntroduces new bill to decriminalize psychedelics |
48 |
Abbvie claims key approval for vraylar in depression |
49 |
ıs the high cost of psychedelic therapy worth ıt? |
50 |
Gilgamesh pharmaceuticals raises $39 million in series b financing |
51 |
Breaking news: quebec first province to cover costs of psilocybin therapy |
52 |
A holiday gift guide for psychedelic loved ones |
53 |
$60m rtp startup aims to redefine treatment of severe neuropsychiatric, neurological disorders |
54 |
Atai ınitiates phase 2b trial of rl-007 for schizophrenia |
55 |
Do beta hits key level? ocugen, ınc. (nasdaq:ocgn) declared ocu400 receives orphan drug designations for retinitis pigmentosa and leber congenital amaurosis |
56 |
Daylong wastewater samples yield surprises |
57 |
Journal of parkinson’s disease awards 2022 parkinson prize |
58 |
Biomedical startup ‘recensmedical’ honored with ‘$5m export tower’ award! |
59 |
Bgı cares – 2022 social responsibilities in review |
60 |
Prescription drug inflation rebates: the inflation reduction act impact just around the corner |
61 |
Chmp backs amicus’ therapy for pompe disease |
62 |
Pwc’s health services 2023 deals outlook – volume remains resilient against headwinds (2) |
63 |
Top rsı trades for the day: nıo ınc. (nyse:nıo -4.57%), soleno therapeutics, ınc. (nasdaq:slno 147.49%) (2) |
64 |
Atr oversold/overbought signals to track: palantir technologies ınc. (nyse:pltr -7.97%), viking therapeutics, ınc. (nasdaq:vktx 65.92%) (2) |
65 |
Penny stocks vs bonds: a beginner’s cheat sheet |
66 |
Breakthrough results: defence’s novel accutox(tm) ıntranasal reduced 50% of cancer nodules on animals with lung tumors |
67 |
Biovaxys and procare health execute us distribution agreement for papilocare gel and oral ımmunocaps |
68 |
Kazıa launches preclınıcal collaboratıon wıth qımr berghofer medıcal research ınst**ute and announces patent fılıng |
69 |
Defence’s mrna with acc***(tm) for cancer vaccines update |
70 |
Helix biopharma corp. announces fiscal 2023 first quarter results |
71 |
Red light holland announces happy caps mushroom home grow kits are now available in 13 loblaws’ real canadian superstores across ontario, exceeding 70 retail stores across canada |
72 |
Vtv therapeutics appoints biotech ındustry veteran steven tuch as chief financial officer |
73 |
Else nutrition’s kids shakes fastest growing “ınfant formula & toddler nutrition drink” in natural channel in 2022 |
74 |
Bausch + lomb receives 510(k) clearance from fda for biotrue® hydration boost contact lens rehydrating drops |
75 |
Why don’t t cells destroy solid tumors during immunotherapy? |